NCT01336569

Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol

Safety and Efficacy of Using the Travoprost/Timolol Fixed Combination (DuoTrav®) in Patients With Open-Angle Glaucoma or Uncontrolled Ocular Hypertension by Beta-blocker Monotherapy (Timolol 0.5%)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to assess the safety and intraocular pressure (IOP)-lowering efficacy of changing to DuoTrav® from prior timolol 0.5% monotherapy in participants with open-angle glaucoma or ocular hypertension.

Conditions

• Glaucoma

Interventions

Type	Name	Description
DRUG	Travoprost 0.004%/timolol maleate 0.5% fixed combination

Timeline

• Start date: 2011-02-01
• Primary completion: 2012-03-01
• Completion: 2012-03-01
• First posted: 2011-04-18
• Last updated: 2013-07-08
• Results posted: 2013-07-08

Locations

1 site across 1 country: United States